Author

Ingrid Slade

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetics· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:DNA methylation· 2 Organism:human· 2 Assay:whole-genome sequencing· 2 Research Focus:benchmarking· 1 Approach:experimental assay· 1 Approach:statistical model· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Angela George· 2 shared Ann Strydom· 2 shared Helen Hanson· 2 shared Nazneen RahmaniD· 2 shared Daniel Riddell· 1 shared Elise RuarkiD· 1 shared Kelly Kohut· 1 shared Mainstreaming Cancer Genetics (MCG) Programme· 1 shared

Activity by Year

2016-2016 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetics

Angela George

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients

Angela George, Daniel Riddell, Sheila Seal, Sabrina Talukdar, Shazia Mahamdallie, Elise Ruark, Victoria Cloke, Ingrid Slade, Zoe Kemp, Martin Gore, Ann Strydom, Susana Banerjee, Helen Hanson, Nazneen Rahman, Mainstreaming Cancer Genetics (MCG) Programme

This study implements a streamlined BRCA gene testing pathway for ovarian cancer patients, achieving high uptake and efficiency with significant cost savings and improved patient outcomes.

bioRxiv · Mar 16, 2016Genetics

A cost analysis of a cancer genetic service model in the UK

Ingrid Slade, Helen Hanson, Angela George, Kelly Kohut, Ann Strydom, Sarah Wordsworth, Nazneen Rahman, MCG Programme

This paper analyzes the costs of BRCA gene testing pathways in a UK cancer genetics service, finding significant cost variation and suggesting cost-efficiency improvements by testing more cancer patients.

Journal of Community Genetics · Feb 27, 2016Peer-reviewedGenetics